Dimensional Fund Advisors’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
Other funds holding FULC
Dimensional Fund Advisors's FULC Position: Q3 2026 in Review
Dimensional Fund Advisors reduced its Fulcrum Therapeutics (FULC) stake by 25% in Q3 2026, selling an estimated $884K and leaving 724,879 shares worth $2.68M. The position accounts for ﹤0.01% of the portfolio, ranked #2647.
Dimensional Fund Advisors first reported a position in FULC in Q1 2021 and has held it in 22 quarters since. The position peaked at $12.3M in Q1 2024. 130 funds tracked by Wall St. Rank hold FULC as of Q3 2026.
- Dimensional Fund Advisors held 724,879 shares of Fulcrum Therapeutics worth $2.68M as of Q3 2026.
- Dimensional Fund Advisors sold 235,668 Fulcrum Therapeutics shares in Q3 2026, an estimated $884K.
- Fulcrum Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #2647 holding.
- Dimensional Fund Advisors first reported a position in Fulcrum Therapeutics in Q1 2021 and has held it in 22 quarters since.
- Dimensional Fund Advisors's Fulcrum Therapeutics position peaked at $12.3M in Q1 2024.
- 130 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q3 2026.
Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.